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Introduction
A growing body of evidence implicates 5-HT 2 receptors (5-HT 2 R) in the pathophysiology 1, 2 and treatment 3 of schizophrenia. Although most attention has focused on the 5-HT 2A R subtype, 5-HT 2C R is also relevant. For example, the behavioural and hallucinogenic effects of lysergic acid diethylamide (LSD) are related to its 5-HT 2C R binding affinity, 4, 5 whilst genetic studies have found associations between the cys23ser polymorphism of the gene and long term hospitalisation in schizophrenia, 6 hallucinations in dementia 7 and therapeutic response to clozapine. 8, 9 Furthermore, recent studies of 5-HT 2C R expression have detected reduced 5-HT 2C R RNA levels in the hippocampus of schizophrenia subjects compared with controls. 10 The importance of this receptor is also emphasized by the fatal neurological deficits observed in 5-HT 2C R knockout mice. 11 5-HT 2C R heterogeneity arises from at least three sources: allelic variation, alternative RNA splicing, 12, 13 and RNA editing. 14 The latter is a potentially important phenomenon, since by changing bases in the mRNA it leads to amino acid substitutions which produce receptor variants with distinct pharmacological properties. 13, 15 First described in rats, RNA editing of 5-HT 2C R also occurs in human brain, at five adenosine sites near the exon 5/intron 5 boundary 14, 16 ( Figure 1 ). Editing involves the enzymatic hydrolytic deamination of one or more of these adenosine residues to inosine, which base pair with cystosine and are read as guanosine during translation. 17 Hybridisation of adjacent complementary sequences in pre-mRNA to form a double stranded (ds) RNA loop are a prerequisite for this process. 14, [18] [19] [20] Four of the variants described in Figure 1 have been shown to be pharmacologically distinct: the unedited 5HT 2C-INI isoform, the partially-edited 5HT 2C-VSV and 5HT 2C-VNV isoforms and the fully edited 5-HT 2C-VGV isoform. Notably the greatest agonist potency is observed with the 5HT 2C-INI form of the receptor, producing several-fold higher second messenger responses to agonist, and existing in a high-affinity G protein-coupled state suggestive of constitutive activity. 15 Clearly the functional relevance of 5-HT 2C R editing is affected by the prevalence and distribution of each isoform; this has not been extensively studied in human brain, but data from one subject show that 5HT 2C-VSV is the most frequent in whole brain, while other variants, including 5HT 2C-INI , are rare. The 5-HT 2C R gene is the only G protein coupled receptor known to be edited. However, this process also occurs in some inonotropic glutamate receptor subunits, and its significance is emphasised by studies of GluR2. Editing of GluR2 determines the calcium permeability of AMPA receptors-a key property with physiological and pathological consequences. 21 Furthermore, region-specific decreases in GluR2 editing have been reported in schizophrenia, 22 warranting study of 5-HT 2C R editing in the disorder. Thus the present study had two main aims. First, to confirm and extend previous findings of 5-HT 2C R RNA editing in human brain; this included assessing whether human 5-HT 2C R RNA contains the ds loop structure predicted to be essential for editing, 14 a search of genomic DNA to see if the edited region contains any sequence variants which may influence the RNA editing process, and the collation of frequency data of 5-HT 2C R RNA edited isoforms in a larger sample of human control subjects than previously studied. The second aim was to investigate whether 5-HT 2C RNA editing is altered in schizophrenia.
Materials and methods

Prediction of RNA secondary structure
Oligonucleotide primers were designed around the site of editing in 5-HT 2C R mRNA using the PRIMER programme. 23 PrimerY4907 was designed from rat intron 3 sequence, 12 assuming it would be similar to the corresponding unknown human sequence. Human genomic DNA extracted from blood samples (Nucleon II, Scotlab, Paisley, Scotland, UK) was amplified by PCR using primers 4998 (5Ј AGC GTC CAT CAT GCA CC 3Ј) and Y4907 (5Ј CTT GTT ACC AGT CGA CG 3Ј). PCR products underwent 1% agarose gel electrophoresis. The band corresponding to the predicted amplified product (228 bp) was excised, purified (Qiaex II, Qiagen, Crawley, UK) and cloned (pGEM-T kit, Promega, Southampton, UK). Sequencing was performed manually (Sequenase 2.0, Amersham Pharmacia, Amersham, UK) revealing the unknown intronic region of the putative dsRNA loop. Computer predictions of secondary structure of the mRNA in the edited region of 5-HT 2C R were performed using the Genebee program. 24 
Mutation detection
Genomic DNA was extracted from lymphocytes using the Nucleon II kit (Scotlab). Ninety-six schizophrenia patients and 24 control subjects were screened for mutations in the putative dsRNA loop region of the 5-HT 2C R gene using the primers 4998 and Y4907 by single stranded conformational analysis (SSCA). 25 The same PCR products underwent 10% non-denaturing PAGE with and without 5% glycerol. The gels were run at 6 V cm −1 for 15 h at room temperature and were repeated for 20 h at 4°C. Thus each sample was run under four different conditions, increasing mutation detection efficiency to approximately 90%. 26 
Brain samples
Frontal cortex frozen tissue (left Brodmann area 46) was available from five normal controls (mean ± SEM: age 51 ± 10 years, post mortem interval 29 ± 6 h, brain pH 6.4 ± 0.2) and five subjects with schizophrenia (mean ± SEM age 59 ± 9 years, post mortem interval 47 ± 10 h, brain pH 6.4 ± 0.1). The two groups did not differ significantly on any of these variables, and each comprised four men and one woman. Schizophrenia was diagnosed according to DMS-IIIR criteria. The patients had all been treated with one or more typical antipsychotic (zuclopenthixol, trifluoperazine, flupenthixol or fluphenazine). All brains were examined neuropathologically and showed no abnormalities.
RT-PCR and sequence analysis
The template DNA used for amplification of the dsRNA loop was cDNA prepared by RT-PCR of RNA extracted as previously described. 27, 28 Two micrograms of RNA were pre-treated at 37°C for 30 min with 1 unit of RQ-1 RNase-free RNase (Promega, Southampton, UK) and 10 units of RNasin RNase inhibitor (Promega) to remove residual genomic DNA, followed by 6 min at 70°C to inactivate the DNase enzyme. Reverse transcription was carried out using 200 units Moloney murine leukaemia virus reverse transcriptase (MMLV) with 10 units of RNase inhibitor (Promega), 30 ng poly dT oligonucleotides (Oswel, Southampton, UK), buffer (50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT) and 0.5 mM of each dNTP (ABgene, Epsom, UK) for each 2 g of RNA isolated. The reaction mixture was incubated at 42°C for 1 h and enzyme activity was terminated by incubation for 10 min at 72°C. The cDNA produced was diluted with 7 parts of sterile deionised water. The subsequent PCR amplification of the 5-HT 2C R RNA edited region was performed using oligonucleotide primers designed to span the human exon 5/intron 5 boundary in order to prevent the amplification of any remaining contaminant genomic DNA. This PCR reaction included template cDNA (10 l of dilution), 1 M of each primer MSF (5Ј TTTCAA CAGCGTCCATCATGCACCT 3Ј) and MSR (5Ј AAC GAAATTTGGGTCGTTGAGCACGCAC 3Ј), 250 M each of dATP, dCTP, dGTP and dTTP, 2 units of Thermoprime DNA Polymerase and recommended buffer (ABgene) in a total volume of 20 l. Samples were amplified for 35 cycles each consisting of 35 s at 96°C, 2 min at 50°C and 2 min at 72°C in a thermal cycler (Hybaid express, Hybaid, Middx, UK) resulting in a 240-bp product. The DNA fragments were resolved by 1% agarose gel electrophoresis, stained with ethidium bromide (50 ng ml −1 ), excised and purified using Qiaex II (Qiagen). The gel-purified DNA was ligated and cloned as described above (pGEM kit, Promega). The plasmid DNA insert from a single bacterial colony represented the edited region of an individual 5-HT 2C R mRNA transcript. Ten clones from each individual were sequenced. These DNA inserts were characterised Molecular Psychiatry either using an ABI377 sequencer (Applied Biosystems, Warrington, UK) or an Alfexpress machine (Amersham Pharmacia Biotech). Alignment of sequences for the detection of RNA edited sites was performed using the MultiAlin program.
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Results
RNA structure of 5HT 2C R Amplification of human genomic DNA in the 5HT 2C R edited region performed using primers Y4907 and primer 4998, produced a 228-bp PCR product, consisted with successful annealing of the rat 5HT 2C R specific primer to the homologous human sequence. The identity of the PCR product was confirmed by DNA sequencing, which revealed a high degree of conservation between the two species in this region, since only eleven nucleotide differences were found. We analysed the secondary structure of the 5HT 2C R mRNA edited region and found that a similar stem-loop double stranded (ds) RNA structure is predicted in both the rat and human sequences (Figure 2 ). This loop is probably responsible for the specificity of RNA editing to this region. 14 The most stable predicted secondary structure had all five adenosines in its stem. Significantly, none of the nucleotide changes between the two species disrupts the base-pairing of the main stem in the predicted structure, supporting the conclusion that the 5-HT 2C R dsRNA loop is likely to exist in both species.
5-HT 2C R RNA editing: schizophrenia vs controls
Sequencing of cDNA clones derived from the human frontal cortex tissues confirmed that the same five adenosine residues were subject to RNA editing as found in the rat brain. In addition to the variants reported previously, two novel isoforms, 5-HT 2C-MNI and 5-HT 2C-VDI , were found in clones sequenced from control tissue ( Table 1) . The most frequent isoform in the control subjects was 5-HT 2C-VSV (28%). We did not detect 5-HT 2C-ISV , 5-HT 2C-IGI , 5-HT 2C-IDV , 5-HT 2C-ISV or 5-HT 2C-IGV which have been reported in other regions of human brain. 13, 15, 16 Clones from the schizophrenia patients showed significantly less editing than those from the control subjects. This was apparent in several ways. There was a reduction in the mean number of 5-HT 2C R RNA editing sites compared with those from the control subjects (ANOVA mean sq = 1.5, F = 6.7, df = 1.9, P = 0.03). When individual editing sites were analysed, a reduction in RNA editing occurred at each site in cases compared with controls, but only the reduction in B site editing (see Figure 1 ) reached significance (chi square = 9.0, df = 1, P = 0.002). This reduction in RNA editing was observed in each individual schizophrenia case (data not shown). Twenty per cent of the clones originating from the schizophrenia cases represented unedited 5-HT 2C-INI isoforms whereas none were found amongst the controls (chi square = 11.1, df = 1, P = 0.001). There was also a smaller number of clones with two or less edited sites in the schizophrenia group (chi Total 50 50 100
Numbers of clones in the schizophrenia group (n = 5) and the control group (n = 5) are grouped according to the amino acid changes predicted by DNA sequencing. Frequencies of the 5-HT 2C-INI , 5-HT 2C-VNV and 5-HT 2C-VSV isoforms differ between the two groups. square = 6.8, df = 1, P = 0.008). These data are summarised in Figure 3 and Table 1 . There was no relationship between RNA editing and age at death, pH or post mortem interval (data not shown).
SSCA
The SSCA screening for variants which might influence 5-HT 2C R RNA editing activity showed no mutations in the genomic DNA from the 96 schizophrenia patients and 24 controls.
Discussion
Our data extend previous evidence for RNA editing of 5-HT 2C R in human brain, 16 in two ways. Firstly, by showing the predicted existence of a stem-loop structure ( Figure 2 ) very similar to that seen in the homologous region of the rat mRNA and which in vitro is essential for editing to occur. 14 The conservation of sequence between rat and human in the key stem region containing the five edited adenosine residues suggests strong selection pressure to conserve this structure, and by implication the importance of editing. Given this structural similarity between the secondary structures of rat and human 5HT 2C R mRNA molecules, it was therefore not surprising to identify RNA editing in the human 5-HT 2C R mRNA. We confirmed that the most abundant isoform in controls is 5HT and that the unedited 5HT 2C-INI variant is extremely rare, indeed was not found in any of our control clones. Two novel 5-HT 2C R RNA edited isoforms were detected, 5HT 2C-MNI and 5HT 2C-VDI (Figure 1) , which have yet to be characterised pharmacologically Molecular Psychiatry and hence their functional significance is unknown. Our failure to detect several other isoforms reported in other areas of human brain 5HT 2C-MSV , 5HT 2C-IDV , 5HT 2C-ISV , 5HT 2C-IGV or 5HT 2C-IGI 13,15 ) may be indicative of region-specific 5-HT 2C R RNA editing, as reported in the rat.
14 However this could just reflect their rarity and therefore that we may have failed to detect them by chance.
Subsequent comparison of sequenced clones originating from frontal cortex of five schizophrenia cases and five controls revealed a decrease in RNA editing in the patients. This was most striking and statistically robust for the 5-HT 2C-INI isoform (absent in controls but present in 10 of 50 clones in the schizophrenia group), and for the decreased editing at the B site which gives rise to 5-HT 2C-VSV , 5-HT 2C-VGV , 5-HT 2C-MNI and 5-HT 2C-VDI isoforms. However, Figure 3a also indicates that a similar trend is present for all editing sites, inferring a global down-regulation or impairment of editing. The underlying molecular mechanism for such an abnormality in schizophrenia is unknown. A primary sequence difference in the 5-HT 2C R gene is unlikely given the negative results of our SSCA analysis, although this method does not allow polymorphisms to be entirely ruled out. 26 Alternatively there may be mutations in the relevant editase enzyme(s), or changes in their regulation. The fact that decreased editing is also seen, albeit less dramatically, for GluR2 in schizophrenia 22 would be consistent with a common underlying abnormality.
Whatever the cause, the known pharmacological differences between the 5-HT 2C R isoforms suggests that, in schizophrenia, endogenous 5-HT might be abnormally potent at frontal cortex 5-HT 2C R sites, due to the presence of an increased number of the more active, unedited 5-HT 2C-INI , and a decreased number of the less active, edited 5-HT 2C-VSV and 5-HT 2C-VNV isoforms. This effect may also alter the response of patients to drugs which have a very high affinity for the 5-HT 2C R, such as clozapine and olanzapine.
We cannot be sure that the RNA editing difference is due to schizophrenia itself. However, we found no suggestion that factors such as age, pH or post mortem interval were responsible, and these factors were similar between groups. The fact that the same trend towards decreased editing was seen in all five subjects with schizophrenia encourages confidence in the results. Although an effect of medication cannot be excluded, it seems unlikely since none of the patients had been treated with antipsychotics with a high enough 5-HT 2C R affinity to alter receptor function, and the RNA editing process is not an obvious target for neurotransmitter ligand. Neverthelesss, the possibility must be considered and is currently under investigation in our laboratory.
In conclusion, we have found reduced 5HT 2C R RNA editing in the prefrontal cortex in schizophrenia patients compared with controls. The greater receptor-G protein coupling efficacy, and increased agonist potency of the unedited 5-HT 2C-INI compared with the major edited isoforms suggests that there may therefore be enhanced 5HT 2C R effects in schizophrenia. This may contribute to the prefrontal cortex dysfunction observed in the disorder. Replication of our finding in a larger sample, and investigation in other brain regions, are required before further speculation about the origins and consequences of reduced 5-HT 2C R RNA editing in schizophrenia are warranted.
